Position in ADCT
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$25,431
-$64,104 QoQ
Shares Held
23,768
-0.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 15 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Saxony Capital Management, LLC holds $25,431 across 1 Drug Manufacturers - Specialty & Generic name. ADCT ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADCT |
ADC Therapeutics SA
This page
|
23,768 | $25,431 |
All Filings in ADCT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,431 | 23,768 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $89,535 | 23,876 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $83,901 | 23,768 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $95,072 | 23,768 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $63,698 | 23,768 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $31,426 | 22,288 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $44,353 | 22,288 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $70,049 | 22,238 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $70,272 | 22,238 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $92,597 | 20,623 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $34,234 | 20,623 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||